Boothbay Fund Management’s Agios Pharmaceuticals AGIO Stock Holding History

Boothbay Fund Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-290,900	Closed	-$11.7M	–	1923
2025 Q3	$11.7M	Buy	+290,900	New	+$10.9M	0.17%	124
2021 Q3	–	Sell	-7,600	Closed	-$419K	–	1865
2021 Q2	$419K	Buy	7,600 +7,504	+7,817%	+$420K	0.01%	1095
2021 Q1	$496K	Buy	+96	New	+$4.75K	0.02%	954
2019 Q3	–	Sell	-93	Closed	-$464K	–	753
2019 Q2	$464K	Sell	93 -220	-70%	-$11.8K	0.04%	432
2019 Q1	$2.11M	Buy	+313	New	+$18.2K	0.2%	114
2016 Q2	–	Sell	-13,700	Closed	-$556K	–	506
2016 Q1	$556K	Buy	+13,700	New	+$586K	0.14%	190

Other funds holding AGIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Boothbay Fund Management's AGIO Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 149,886 shares worth $5.56M. The stake represents 0.07% of the portfolio and ranks #317 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in AGIO as recently as Q4 2025.

Boothbay Fund Management first reported a position in AGIO in Q1 2021 and has held it in 14 quarters since. The position peaked at $19.9M in Q3 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

Boothbay Fund Management held 149,886 shares of Agios Pharmaceuticals worth $5.56M as of Q2 2026.
Agios Pharmaceuticals was a new Boothbay Fund Management position in Q2 2026.
Agios Pharmaceuticals made up 0.07% of Boothbay Fund Management's portfolio in Q2 2026, its #317 holding.
Boothbay Fund Management first reported a position in Agios Pharmaceuticals in Q1 2021 and has held it in 14 quarters since.
Boothbay Fund Management's Agios Pharmaceuticals position peaked at $19.9M in Q3 2025.
238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.